Several studies indicated OPN expression in various human malignancies, acting as a marker of malignancy in prostate cancer, osteosarcoma, glioblastoma, squamos cell carcinoma, breast cancer and melanoma (reviewed in ref. 33). Here, SPP1 is linked to melanoma.